ClearLight Biotechnologies

Growth Stage

The Next Dimension in Tissue Analysis



Self Managed

Start Date


Close Date


Max. Goal


Min. Investment


Security Type

Equity - Common

Funding Type



Series A

Price Per Share


Pre-Money Valuation



Sunnyvale, California


Healthcare & Pharmaceuticals

Tech Sector


Distribution Model




Capital Intensity


Business Type


ClearLight Biotechnologies is raising funds independently through Reg A+ crowdfunding. It is a life sciences tools company that provides tissue processing, imaging, and image analysis services to pharmaceutical and biotechnology companies. The company uses its CLARITY technology that helps clear thick animal and human tissue so the tissue samples can be imaged in three dimensions. ClearLight Biotechnologies is an emerging growth company and generated $32,000 in gross revenue in 2020. Karl Deisseroth founded ClearLight Biotechnologies in 2014. The current crowdfunding campaign has no minimum target and a maximum target of $240,000. The campaign proceeds will be used for research and development and working capital.

Balance Sheet

Cash and Cash Equivalents


Accounts and Notes Receivable


Property, Plant and Equipment (PP&E)


Total Assets


Accounts Payable & Accrued Liabilities


Total Liabilities


Total Stockholders' Equity


Total Liabilities and Equity


Statement of Comprehensive Income Information

Total Revenues


Costs & Expenses Applicable to Rev


Depreciation and Amortization


Net Income


Earnings Per Share - Basic


Earnings Per Share - Diluted


Financials as of: 11/18/2021
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
ClearLight Biotechnologies on Self Managed 2021
Platform: Self Managed
Security Type: Equity - Common
Valuation: $13,611,972

Follow company

Follow ClearLight Biotechnologies on Self Managed 2021
View Deal Page (Closed)
Bullish / Bearish
You're Bullish on ClearLight Biotechnologies on Self Managed 2021

Thank you for your vote on ClearLight Biotechnologies on Self Managed 2021

Bullish / Bearish
You're Bearish on ClearLight Biotechnologies on Self Managed 2021

Thank you for your vote on ClearLight Biotechnologies on Self Managed 2021